🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of this study is to evaluate the efficacy in terms of clinical and ...
Status
Completed
Location
Instituto de Estudios de Mastocitosis de Castilla La Mancha; Hospital Virgen del Valle
Start Date
2011-01
Trial ID
NCT01297777
Treatments Being Tested
A randomized, double-blind, placebo-controlled phase III study of regorafen...
Status
Completed
Location
Multiple Locations
Start Date
2011-01-04
Trial ID
NCT01271712
Treatments Being Tested
Some rare cancers are hard-to-treat and patients have a poor prognosis. It ...
Status
Recruiting
Location
Oslo University Hospital
Start Date
2025-03-20
Trial ID
NCT06119789
Treatments Being Tested
This study is designed to determine whether the combination treatment of Pa...
Status
Terminated
Location
NYU cancer center
Start Date
2007-04
Trial ID
NCT00840450
Treatments Being Tested
The objective of this Phase II, open-label, multicenter, non-randomised con...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-01-01
Trial ID
NCT06692491
Treatments Being Tested
To characterize pharmacokinetic profile of test product compared to that of...
Status
Completed
Location
Kailash Cancer Hospital & Research Centre
Start Date
2014-02
Trial ID
NCT02103322
Treatments Being Tested
RATIONALE: Imatinib mesylate may stop the growth of tumor cells by blocking...
Status
Completed
Location
University of Chicago Cancer Research Center
Start Date
2002-07
Trial ID
NCT00045669
Treatments Being Tested
This is a second Pilot Study to determine the efficacy of Gleevec® in neuro...
Status
Completed
Location
Riley Hospital for Children
Start Date
2012-02
Trial ID
NCT01140360
Treatments Being Tested
Following the ACOSOG Z9001trial, imatinib received market authorization in ...
Status
Unknown
Location
Multiple Locations
Start Date
2015-10
Trial ID
NCT02576080
Treatments Being Tested
Objectives: * To determine the maximum tolerated dose (MTD) of imatinib me...
Status
Terminated
Location
University of Texas MD Anderson Cancer Center
Start Date
2003-12-29
Trial ID
NCT00506779
Treatments Being Tested